Janssen Enters into Collab with Theravance Biopharma for Oral Drug Candidate for Inflammatory Bowel Disease

NewsThe Janssen Pharmaceutical Companies of Johnson & Johnson announced their entry into a worldwide collaboration with an affiliate of Theravance Biopharma Inc. to develop TD1473 a firstinclass oral gastrointestinal GI restricted panJanus kinase JAK i...